• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    American Oncology Network Announces the Commencement of OTCQX Trading

    6/10/24 7:15:00 AM ET
    $AONC
    Medical/Nursing Services
    Health Care
    Get the next $AONC alert in real time by email

    FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc.  (AON) (OTCQX:AONC), a rapidly-growing network of community-based oncology practices, today announced it has qualified to trade on the OTCQX® Best Market. AON previously traded on NASDAQ.

    The OTCQX Best Market provides value and convenience to U.S. investors, brokers and institutions seeking to trade AONC. The OTCQX Best Market is OTC Markets Group's premier market for established, investor-focused U.S. and international companies. It offers investors transparent trading in companies that meet high financial standards, follow best practice corporate governance, and demonstrate compliance with U.S. securities laws. OTCQX quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

    "We're pleased to qualify for the OTCQX Market to provide investors transparent trading at OTC Markets Group's highest tier," said Todd Schonherz, AON's chief executive officer. "Trading on OTCQX will provide shareholders transparency and convenience as we continue to expand our reach and provide patients quality, affordable, and accessible cancer care in communities across the nation. We are confident in the long-term value creation opportunity of our business as we look forward to continuing to update the market on our performance in the coming quarters."

    Class A Common Stock of American Oncology Network, Inc. begins trading today on OTCQX under the symbol "AONC." Warrants of American Oncology Network, Inc. begins trading today on the OTCQB under the symbol "AONCW." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

    About OTC Markets Group, Inc.

    OTC Markets Group, Inc. (OTCQX:OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market. Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets. OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC. To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

    About American Oncology Network, Inc.

    American Oncology Network, Inc. (AON) (OTCQX:AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON's rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at www.AONcology.com.

    Forward-Looking Statements

    Certain statements in this press release are forward-looking statements. Forward-looking statements generally relate to future events including future financial or operating performance of American Oncology Network, Inc. ("AON"). Forward-looking statements generally relate to future events or AON's future financial or operating performance. For example, projections of future revenue and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expect", "intend", "will", "estimate", "anticipate", "believe", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by AON and its management, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond AON's control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (2) costs related to operating as a public company (3) changes in applicable laws or regulations; (4) the possibility that AON may be adversely affected by other economic, business, and/or competitive factors; (5) AON's estimates of expenses and profitability; and (6) other risks and uncertainties set forth in the section entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in AON's annual report on Form 10-K filed with the SEC on March 28, 2024, as amended, and in its quarterly reports and current reports subsequently filed with the SEC. AON cautions that the foregoing list of factors is not exclusive or exhaustive and investors should not place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. If any of these risks materialize or AON's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that AON does not presently know or that AON currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect AON's expectations, plans or forecasts of future events and views as of the date of this communication. New AON anticipates that subsequent events and developments will cause AON's assessments to change. However, while AON may elect to update these forward-looking statements at some point in the future, AON specifically disclaims any obligation to do so, unless required by applicable law. These forward-looking statements should not be relied upon as representing AON's assessments as of any date subsequent to the date of this communication. AON does not give any assurance that AON will achieve its expectations. Accordingly, undue reliance should not be placed upon the forward-looking statements.

    Investor Contact:

    Solebury Strategic Communications

    [email protected]

    Media Contact:

    Karen Riley Sawyer

    [email protected]



    Primary Logo

    Get the next $AONC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AONC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AONC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Divers Stephen bought $10,750 worth of shares (5,000 units at $2.15), increasing direct ownership by 9% to 62,470 units (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      5/30/24 3:47:35 PM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Schonherz Todd bought $9,962 worth of shares (5,340 units at $1.87) (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      5/30/24 3:41:32 PM ET
      $AONC
      Medical/Nursing Services
      Health Care

    $AONC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah

      CASA GRANDE, Ariz., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Community oncology practice Cancer and Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network (AON) (OTCQX:AONC), is pleased to welcome Board-certified medical oncologist Ronak Rakesh Shah, DO, to its physician care team. Dr. Shah is now accepting patients at the Casa Grande clinic. Dr. Shah is a Board-certified medical oncologist and hematologist. He earned his medical degree from Michigan State University College of Osteopathic Medicine,    completed his residency at McLaren Macomb Hospital, and completed a fellowship in hematology and oncology at Larkin Community Hospital, an affiliate of Nova Southeast

      1/2/25 8:00:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

      INDIANAPOLIS, IN., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of Indiana (HOI), a partner practice of American Oncology Network (AON) (OTCQX:AONC), presented clinically meaningful and socially impactful research findings at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held Dec. 7-10 in San Diego. The ASH Annual Meeting is recognized as a premier event for hematology research, with more than 5,000 scientific abstracts submitted each year. Accepted abstracts undergo rigorous peer review, with selected presentations showcasing sign

      12/30/24 8:00:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation

      FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX:AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC). Accreditation is a process through which health care organizations demonstrate compliance with national standards. ACHC accreditation reflects an organization's dedication to meeting standards that facilitate a higher level of performance and patient care. ACHC, a nonprofit organization, has been a symbol of quality and excellence since 1986. It is ISO 9001:2015 certified and has Centers for M

      12/19/24 8:00:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care

    $AONC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Valle William was granted 5,000 shares, increasing direct ownership by 33% to 19,981 units (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      7/18/24 4:47:14 PM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Director Fluegel Bradley M was granted 5,000 shares, increasing direct ownership by 13% to 44,981 units (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      7/18/24 4:46:16 PM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Chief Medical Officer Divers Stephen was granted 36,000 shares, increasing direct ownership by 58% to 98,470 units (SEC Form 4)

      4 - American Oncology Network, Inc. (0001839998) (Issuer)

      7/18/24 4:45:27 PM ET
      $AONC
      Medical/Nursing Services
      Health Care

    $AONC
    Leadership Updates

    Live Leadership Updates

    See more
    • Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah

      CASA GRANDE, Ariz., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Community oncology practice Cancer and Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network (AON) (OTCQX:AONC), is pleased to welcome Board-certified medical oncologist Ronak Rakesh Shah, DO, to its physician care team. Dr. Shah is now accepting patients at the Casa Grande clinic. Dr. Shah is a Board-certified medical oncologist and hematologist. He earned his medical degree from Michigan State University College of Osteopathic Medicine,    completed his residency at McLaren Macomb Hospital, and completed a fellowship in hematology and oncology at Larkin Community Hospital, an affiliate of Nova Southeast

      1/2/25 8:00:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann

      CAPE CORAL, FL.,, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX:AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients. The new Cape Coral clinic – located at 326 Del Prado Blvd, Suite 301 – offers Cape Coral-area patients further opportunity to choose a community oncology care practice that best

      10/22/24 8:05:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • American Oncology Network Appoints New Board Member

      FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William "Bill" J. Valle to its Board of Directors, effective April 19, 2024. "On behalf of the Board, I am honored to be officially welcoming Bill," said Stephen "Fred" Divers, MD, AON's chief medical officer and vice chairman of the Board. "Bill has extensive experience and knowledge that will help guide AON on its mission forward. His fresh perspectives and insights will serve as a catalyst for innovation as we continue to close the cancer care gap and improve access to c

      5/16/24 4:30:00 PM ET
      $AONC
      Medical/Nursing Services
      Health Care

    $AONC
    Financials

    Live finance-specific insights

    See more
    • American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call

      FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (OTCQX:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13748211. A replay will be available two hours after the call and can be accessed by dialing 1-844-5

      7/31/24 8:00:00 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • American Oncology Network, Inc. Announces First Quarter 2024 Financial Results

      First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new providers to the AON platform Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (NASDAQ:AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three-month period ("First Quarter 2024") ended March 31, 2024. Todd Schonherz, AONC chief executive officer, commented, "We delivered strong revenue growth in the first qua

      5/15/24 4:47:31 PM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call

      FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13746298. A replay will be available two hours after the call and can be accessed by

      5/14/24 8:10:19 AM ET
      $AONC
      Medical/Nursing Services
      Health Care

    $AONC
    SEC Filings

    See more
    • SEC Form 10-K filed by American Oncology Network Inc.

      10-K - American Oncology Network, Inc. (0001839998) (Filer)

      3/27/25 5:22:16 PM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • SEC Form 15-15D filed by American Oncology Network Inc.

      15-15D - American Oncology Network, Inc. (0001839998) (Filer)

      1/2/25 6:01:19 AM ET
      $AONC
      Medical/Nursing Services
      Health Care
    • Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K/A - American Oncology Network, Inc. (0001839998) (Filer)

      12/26/24 12:11:27 PM ET
      $AONC
      Medical/Nursing Services
      Health Care